-
Infusion-related events during natalizumab: No need for post-infusion monitoring
Loonstra, F. C., van Rossum, J. A., van Kempen, Z. L. E., Rispens, T., Uitdehaag, B. M. J. & Killestein, J., 1 Oct 2020, In: Multiple sclerosis (Houndmills, Basingstoke, England). 26, 12, p. 1590-1593 4 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
COVID-19 in multiple sclerosis: The Dutch experience: The Dutch experience
Loonstra, F. C., Hoitsma, E., van Kempen, Z. L. E., Killestein, J. & Mostert, J. P., 1 Sept 2020, In: Multiple sclerosis (Houndmills, Basingstoke, England). 26, 10, p. 1256-1260 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy
Loonstra, F. C., Verberk, I. M. W., Wijburg, M. T., Wattjes, M. P., Teunissen, C. E., van Oosten, B. W., Uitdehaag, B. M. J., Killestein, J. & van Kempen, Z. L. E., 1 Aug 2019, In: Annals of neurology. 86, 2, p. 322-324 3 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
